Magali Roy is the Investment Lead for the Norrsken Accelerator, focusing on finding the best startups at pre-seed and seed stage around the world that are having a large and positive impact. Before this, she worked at the leading market access platform for impact investing based in Geneva, Switzerland, called Symbiotics. She has also worked within the world of global public health, primarily within enabling vaccinations in emerging markets as well as better nutrition. Whilst in Geneva, she also worked on a paper with the World Health Organization to better understand the role of global health initiatives when financing public health systems, before moving to the world of impact investing.